Key facts and Forecast
Financial results of Q1 2024
- Healthcare with strong performance
- Electronics increases sales and earnings organically, driven by higher demand for semiconductor materials
- Inventory destocking in Life Science continues; sales recovery expected in the second half of the year
- Net sales down organically by 1.2% to € 5.1 billion
- EBITDA pre decreases organically by 5.2% to € 1.5 billion
Forecast for fiscal 2024
- Qualitative guidance confirmed with Merck KGaA, Darmstadt, Germany returning to organic growth
- Net sales: in a range of € 20.6 billion to € 22.1 billion, organically +1% to +5%
- EBITDA pre: in a range of € 5.7 billion to € 6.3 billion, organically +1% to +7%
Overview: business performance in Q1 2024
| Q1 2024 (in € billion) | Change (in %, compared to Q1 2023) | Organic change (in %, compared to Q1 2023) |
|---|---|---|---|
Group net sales |
5.1 |
-3.3 |
-1.2 |
EBITDA pre |
1.5 |
‑8.4 |
‑5.2 |
Life Science sales |
2.1 |
-13.8 |
-12.6 |
Healthcare sales |
2.0 |
7.5 |
10.1 |
Electronics sales |
0.9 |
3.1 |
6.3 |
We had a good start to the year and gained initial momentum in the first quarter of 2024, once again benefiting from our diversified business model. We expect acceleration in the second half of the year, especially in Life Science, and thus a gradual return to organic growth for the Group in fiscal 2024.
-
![Brochure title]()
Quarterly Statement Q1 2024
Download (PDF)Detailed information about the development of our business in the first quarter of 2024.
ADDITIONAL INFORMATION
Downloads for the Media
Additional Downloads
- Presentation for Analysts (PDF)
- Financial Statement (XLS)
- Financial Statement (PDF)
- Regional Sector Sales (XLS)
- Summary (PDF)
Conference calls for the media and analysts
- The conference call for the media and the conference call for analysts are available as a recording
Related News
View All News-
Press Releases
Off to a Good Start in Fiscal 2024
The positive development of Healthcare and Electronics largely compensated for the decline in Life Science.
2024/05/15
Upcoming Events
View All EventsOur Q2 2024 results will be published on August 1, 2024, at 7 a.m. (CEST). Our conference call for the media will take place at 9:30 a.m. (CEST), and the conference call for analysts at 2 p.m. (CEST).
Our Q3 2024 results will be published on November 14, 2024, at 7 a.m. (CET). Our conference call for the media will take place at 9:30 a.m. (CET), and the conference call for analysts at 2 p.m. (CET).
Annual Reports Archive
Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
Check Share Price